Medplus Health Services (BOM:543427) Debt-to-EBITDA : 2.17 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Medplus Health Services Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Medplus Health Services's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹1,415 Mil. Medplus Health Services's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹8,681 Mil. Medplus Health Services's annualized EBITDA for the quarter that ended in Mar. 2024 was ₹4,653 Mil. Medplus Health Services's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 2.17.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Medplus Health Services's Debt-to-EBITDA or its related term are showing as below:

BOM:543427' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 2.49 Med: 2.78 Max: 3.31
Current: 2.56

During the past 6 years, the highest Debt-to-EBITDA Ratio of Medplus Health Services was 3.31. The lowest was 2.49. And the median was 2.78.

BOM:543427's Debt-to-EBITDA is ranked worse than
50.35% of 429 companies
in the Healthcare Providers & Services industry
Industry Median: 2.55 vs BOM:543427: 2.56

Medplus Health Services Debt-to-EBITDA Historical Data

The historical data trend for Medplus Health Services's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medplus Health Services Debt-to-EBITDA Chart

Medplus Health Services Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-EBITDA

Get a 7-Day Free Trial

3.18

2.49

2.68

2.88

2.56

Medplus Health Services Quarterly Data
	Mar19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-EBITDA	Get a 7-Day Free Trial												2.36	-	2.51	-	2.17

Competitive Comparison of Medplus Health Services's Debt-to-EBITDA

For the Pharmaceutical Retailers subindustry, Medplus Health Services's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medplus Health Services's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medplus Health Services's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Medplus Health Services's Debt-to-EBITDA falls into.

Medplus Health Services Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Medplus Health Services's Debt-to-EBITDA for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(1414.86	+	8680.83)	/	3940.9
	=	2.56

Medplus Health Services's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(1414.86	+	8680.83)	/	4653.04
	=	2.17

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.

Medplus Health Services (BOM:543427) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Medplus Health Services Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Medplus Health Services's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Medplus Health Services (BOM:543427) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Medplus Health Services Ltd (BOM:543427) » Definitions » Debt-to-EBITDA

Traded in Other Exchanges

MEDPLUS:India

Address

Opposite Railway Siding (Moosapet), Municipal No: 11-6-56, Survey No. 257 & 258/1, C Block, III Floor, Kukatpally, Hyderabad, TG, IND, 500 037

Website

https://www.medplusindia.com

Medplus Health Services Ltd is a pharmacy retailer. It offers pharmaceutical and wellness products such as medicines, vitamins, medical devices, test kits, and others. The company also offer an omnichannel platform wherein customers can purchase products through stores, place orders over the telephone, online orders, and a Click and Pick facility.

Medplus Health Services (BOM:543427) Headlines

No Headlines